Literature DB >> 30684274

Role of TGF-β signaling regulatory microRNAs in the pathogenesis of colorectal cancer.

Atena Soleimani1, Majid Khazaei2,3, Gordon A Ferns4, Mikhail Ryzhikov5, Amir Avan2,6, Seyed Mahdi Hassanian1,2.   

Abstract

Transforming growth factor β (TGF-β) modulates tumor progression by regulating cell proliferation, apoptosis, metastasis, angiogenesis, and drug resistance. Biological and pharmacological agonists/antagonists, the interplay between intracellular signaling pathways, and microRNAs (miRNAs) control the initiation and activation of the TGF-β signaling pathway. It has been proposed that the expression profiles of tumor suppressor and oncogenic TGF-β miRNAs may be used for the classification, diagnosis, and prognosis of human malignancies. Deregulated miRNAs and aberrant activation of TGF-β signaling are frequently found in human colorectal cancers (CRCs), but a little is known about their mechanisms of action in the development and progression of colorectal carcinoma. This review summarizes the current knowledge of the role of TGF-β signaling regulatory miRNAs in the pathogenesis of CRC for a better understanding and hence better management of this disease.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  TGF-β signaling; colorectal cancer; microRNA

Year:  2019        PMID: 30684274     DOI: 10.1002/jcp.28169

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer.

Authors:  Qiliang Peng; Yi Shen; Peifeng Zhao; Ming Cheng; Yaqun Zhu; Bo Xu
Journal:  BMC Cancer       Date:  2020-06-03       Impact factor: 4.430

2.  Recombinant production, purification, crystallization, and structure analysis of human transforming growth factor β2 in a new conformation.

Authors:  Laura Del Amo-Maestro; Laura Marino-Puertas; Theodoros Goulas; F Xavier Gomis-Rüth
Journal:  Sci Rep       Date:  2019-06-17       Impact factor: 4.379

3.  UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.

Authors:  Dan Jin; Jiwei Guo; Yan Wu; Jing Du; Xiaohong Wang; Jiajia An; Baoguang Hu; Lingqun Kong; Weihua Di; Wansheng Wang
Journal:  Theranostics       Date:  2019-03-17       Impact factor: 11.556

4.  Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer.

Authors:  Huimin Liu; Xiaoyu Gu; Guihua Wang; Ying Huang; Shaoqing Ju; Jianfei Huang; Xudong Wang
Journal:  Aging (Albany NY)       Date:  2019-08-22       Impact factor: 5.682

Review 5.  Nanoparticles Targeting STATs in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Zahra Ahmadi; Niranjan G Kotla; Elham Ghasemipour Afshar; Saeed Samarghandian; Ali Mandegary; Abbas Pardakhty; Reza Mohammadinejad; Gautam Sethi
Journal:  Cells       Date:  2019-09-27       Impact factor: 6.600

Review 6.  Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.

Authors:  Milad Ashrafizadeh; Hossein Rafiei; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2021-01-21       Impact factor: 5.722

7.  The Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell Line.

Authors:  Krzysztof Januszyk; Piotr Januszyk; Beniamin O Grabarek; Dariusz Boroñ; Marcin Oplawski
Journal:  Curr Pharm Biotechnol       Date:  2020       Impact factor: 2.837

8.  Clinical and molecular assessment of an onco-immune signature with prognostic significance in patients with colorectal cancer.

Authors:  Pankaj Ahluwalia; Ashis K Mondal; Meenakshi Ahluwalia; Nikhil S Sahajpal; Kimya Jones; Yasmeen Jilani; Gagandeep K Gahlay; Amanda Barrett; Vamsi Kota; Amyn M Rojiani; Ravindra Kolhe
Journal:  Cancer Med       Date:  2022-02-09       Impact factor: 4.452

9.  Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE).

Authors:  Archana Thakur; Sri Vidya Kondadasula; Kyungmin Ji; Dana L Schalk; Edwin Bliemeister; Johnson Ung; Amro Aboukameel; Eli Casarez; Bonnie F Sloane; Lawrence G Lum
Journal:  Cancer Immunol Immunother       Date:  2020-08-31       Impact factor: 6.968

10.  MicroRNA-135b/CAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling.

Authors:  Longtao Huangfu; Qifei He; Jing Han; Jingyao Shi; Xiaomei Li; Xiaojing Cheng; Ting Guo; Hong Du; Wanhong Zhang; Xiangyu Gao; Fengming Luan; Xiaofang Xing; Jiafu Ji
Journal:  Int J Biol Sci       Date:  2021-05-10       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.